Active versus passive cocaine administration: Differences in the neuroadaptive changes in the brain dopaminergic system

Brain Research

Volumn 1157, Issue 1, 2007, Pages 1-10

  Stefański, Roman ^a,c   Ziółkowska, Barbara ^b   Kuśmider, Maciej ^b   Mierzejewski, Paweł ^a   Wyszogrodzka, Edyta ^a   Kołomańska, Paulina ^a   Dziedzicka Wasylewska, Marta ^b   Przewłocki, Ryszard ^b   Kostowski, Wojciech ^a,c  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autoradiography; Cocaine; Dopamine D2 receptor; In situ hybridization; Self administration

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; MESSENGER RNA;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG SELF ADMINISTRATION; IN VITRO STUDY; LIMBIC CORTEX; MALE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; RECEPTOR DENSITY; RECEPTOR GENE; RECEPTOR INTRINSIC ACTIVITY; VENTRAL TEGMENTUM;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; MALE; NEOSTRIATUM; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); RNA, MESSENGER; SELF ADMINISTRATION; VENTRAL TEGMENTAL AREA;

RATTUS;

EID: 34250639466     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.074     Document Type: Article

References (62)

1. Abi-Dargham A., Kegeles L.S., Martinez D., Innis R.B., and Laruelle M. Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naive healthy volunteers: results from a large cohort. Eur. Neuropsychopharmacol. 13 (2003) 459-468
2. Alburges M.E., Narang N., and Wamsley J.K. Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14 (1993) 314-323
3. 2 dopamine receptor cDNA. Nature 336 (1998) 783-787
4. Butcher S.P., Fairbrother I.S., Kelly J.S., and Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50 (1988) 346-355
5. Cheramy A., Leviel V., and Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 289 (1981) 537-542
6. Claye L.H., Akunne H.C., Davis M.D., DeMattos S., and Soliman K.F. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Mol. Neurobiol. 11 (1995) 55-66
7. De La Garza II R., and Madras B.K. [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse 37 (2000) 232-244
8. 4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res. Mol. Brain Res. 45 (1997) 1-12
9. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375 (1999) 13-30
10. Evans S.M., Walsh S.L., Levin F.R., Foltin R.W., Fischman M.W., and Bigelow G.E. Effect of flupentixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug Alcohol Depend. 64 (2001) 271-283
11. Fischer J.F., and Cho A.K. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208 (1979) 203-209
12. Fischman M.W. Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs. NIDA Res. Monogr. 92 (1989) 211-230
13. Fischman M.W., Foltin R.W., Nestadt G., and Pearlson G.D. Effects of desipramine maintenance on cocaine self-administration by humans. J. Pharmacol. Exp. Ther. 253 (1990) 760-770
14. Foltin R.W., and Fischman M.W. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J. Pharmacol. Exp. Ther. 278 (1996) 1153-1164
15. Georges F., and Aston-Jones G. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 28 (2003) 1140-1149
16. Gerrits M.A., Petromilli P., Westenberg H.G., Di Chiara G., and van Ree J.M. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res. 924 (2002) 141-150
17. Goeders N.E., and Kuhar M.J. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens. Alcohol Drug Res. 7 (1987) 207-216
18. 1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl) 143 (1999) 102-110
19. Harris J.E., and Baldessarini R.J. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology 12 (1973) 669-679
20. Heinz A., Siessmeier T., Wrase J., Hermann D., Klein S., Grusser S.M., Flor H., Braus D.F., Buchholz H.G., Grunder G., Schreckenberger M., Smolka M.N., Rosch F., Mann K., and Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am. J. Psychiatry 161 (2004) 1783-1789
21. Jacobs E.H., Smit A.B., de Vries T.J., and Schoffelmeer A.N. Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol. Sci. 24 (2003) 566-573
22. 2 receptor function. J. Pharmacol. Exp. Ther. 269 (1994) 743-749
23. Kish S.J., Kalasinsky K.S., Derkach P., Schmunk G.A., Guttman M., Ang L., Adams V., Furukawa Y., and Haycock J.W. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 24 (2001) 561-567
24. 2 dopamine receptors in rat brain. Brain Res. 532 (1990) 265-270
25. Lamb R.J., Preston K.L., Schindler C.W., Meisch R.A., Davis F., Katz J.L., Henningfield J.E., and Goldberg S.R. The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J. Pharmacol. Exp. Ther. 259 (1991) 1165-1173
26. Laurier L.G., Corrigall W.A., and George S.R. Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res. 634 (1994) 31-40
27. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., and Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 230-234
28. Madras B.K., Fahey M.A., Bergman J., Canfield D.R., and Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251 (1989) 131-141
29. Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang D.R., Huang Y., Cooper T., Kegeles L., Zarahn E., Abi-Dargham A., Haber S.N., and Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23 (2003) 285-300
30. 2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29 (2004) 1190-1202
31. Meador-Woodruff J.H., Little K.Y., Damask S.P., Mansour A., and Watson S.J. Effects of cocaine on dopamine receptor gene expression: a study in the postmortem human brain. Biol. Psychiatry 34 (1993) 348-355
32. 2 receptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 8560-8564
33. 2 receptors in rhesus monkeys. Synapse 30 (1998) 88-96
34. 2 receptors and cocaine self-administration. Nat. Neurosci. 5 (2002) 169-174
35. 2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am. J. Psychiatry 162 (2005) 1473-1482
36. Nader M.A., Daunais J.B., Moore T., Nader S.H., Moore R.J., Smith H.R., Friedman D.P., and Porrino L.J. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 27 (2002) 35-46
37. 2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 9 (2006) 1050-1056
38. Neisewander J.L., Lucki I., and McGonigle P. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Synapse 16 (1994) 1-10
39. Nestler E.J., Terwilliger R.Z., Walker J.R., Sevarino K.A., and Duman R.S. Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J. Neurochem. 55 (1990) 1079-1082
40. Parker E.M., and Cubeddu L.X. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J. Pharmacol. Exp. Ther. 245 (1988) 199-210
41. Porrino L.J., Lyons D., Miller M.D., Smith H.R., Friedman D.P., Daunais J.B., and Nader M.A. Metabolic mapping of the effects of cocaine during the initial phases of self-administration in the nonhuman primate. J. Neurosci. 22 (2002) 7687-7694
42. Raiteri M., Bertollini A., Angelini F., and Levi G. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur. J. Pharmacol. 34 (1975) 189-195
43. Reith M.E., Sershen H., and Lajtha A. Saturable (3H)cocaine binding in central nervous system of mouse. Life Sci. 27 (1980) 1055-1062
44. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
45. 3 receptors in the rat brain differentiated by agonist and antagonist binding-an autoradiographic analysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 359 (1999) 178-186
46. Rossetti Z.L., Melis F., Carboni S., and Gessa G.L. Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. Ann. N.Y. Acad. Sci. 654 (1992) 513-516
47. Stefanski R., Ladenheim B., Lee S.H., Cadet J.L., and Goldberg S.R. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur. J. Pharmacol. 371 (1999) 123-135
48. Stefanski R., Justinova Z., Hayashi T., Takebayashi M., Goldberg S.R., and Su T.P. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology (Berl) 175 (2004) 68-75
49. Striplin C.D., and Kalivas P.W. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 14 (1993) 10-15
50. Taylor D.L., Ho B.T., and Fagan J.D. Increased dopamine receptor binding in rat brain by repeated cocaine injections. Commun. Psychopharmacol. 3 (1979) 137-142
51. Tropea D., Capsoni S., Tongiorgi E., Giannotta S., Cattaneo A., and Domenici L. Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience. Eur. J. Neurosci. 13 (2001) 709-721
52. Trulson M.E., and Ulissey M.J. Chronic cocaine administration decreases dopamine synthesis rate and increases [3H] spiroperidol binding in rat brain. Brain Res. Bull. 19 (1987) 35-38
53. Tupala E., and Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 1221-1247
54. 2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14 (1993) 169-177
55. 2 receptor levels. Am. J. Psychiatry 156 (1999) 1440-1443
56. 2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158 (2001) 2015-2021
57. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 47 Suppl 1 (2004) 3-13
58. 3 receptors. Synapse 23 (1996) 152-163
59. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225
60. Young III W.S., Bonner T.I., and Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 9827-9831
61. Zeigler S., Lipton J., Toga A., and Ellison G. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res. 552 (1991) 27-35
62. Ziółkowska B., Stefanski R., Mierzejewski P., Zapart G., Kostowski W., and Przewłocki R. Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain. Brain Res. 1069 (2006) 1-9